292.05
前日終値:
$284.53
開ける:
$283.72
24時間の取引高:
2.87M
Relative Volume:
1.51
時価総額:
$76.94B
収益:
$216.66B
当期純損益:
$6.25B
株価収益率:
13.16
EPS:
22.1869
ネットキャッシュフロー:
$7.44B
1週間 パフォーマンス:
+6.54%
1か月 パフォーマンス:
+2.56%
6か月 パフォーマンス:
+8.18%
1年 パフォーマンス:
+1.68%
Cigna Group Stock (CI) Company Profile
Compare CI vs UNH, CVS, ELV, HUM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CI
Cigna Group
|
292.05 | 74.96B | 216.66B | 6.25B | 7.44B | 22.19 |
|
UNH
Unitedhealth Group Inc
|
276.65 | 243.26B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
78.35 | 96.90B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
338.98 | 73.84B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
193.94 | 23.28B | 126.36B | 1.30B | 1.55B | 10.67 |
Cigna Group Stock (CI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-14 | 開始されました | Goldman | Buy |
| 2025-02-06 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Piper Sandler | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2024-02-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-02-05 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-02-01 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-01-04 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2023-12-11 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-06-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Neutral |
| 2023-04-05 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-01-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-11-21 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-07-14 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-22 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Hold |
| 2022-05-27 | 再開されました | Bernstein | Mkt Perform |
| 2022-05-26 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-05-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-05-09 | アップグレード | Cowen | Market Perform → Outperform |
| 2022-02-07 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-02-04 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-01-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-12-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 開始されました | Goldman | Neutral |
| 2021-11-17 | 開始されました | Seaport Research Partners | Buy |
| 2021-09-27 | 開始されました | SVB Leerink | Mkt Perform |
| 2021-09-10 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-06 | 繰り返されました | BofA Securities | Buy |
| 2021-08-06 | 繰り返されました | Citigroup | Buy |
| 2021-08-06 | 繰り返されました | Deutsche Bank | Buy |
| 2021-08-06 | 繰り返されました | Jefferies | Buy |
| 2021-08-06 | 繰り返されました | Mizuho | Buy |
| 2021-08-06 | 繰り返されました | Oppenheimer | Outperform |
| 2021-08-06 | 繰り返されました | Truist | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-04 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-03-24 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-12-11 | ダウングレード | Wells Fargo | Market Perform → Underperform |
| 2019-10-18 | 開始されました | Mizuho | Buy |
| 2019-09-30 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-08-06 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2019-04-23 | 開始されました | UBS | Buy |
| 2019-01-14 | 開始されました | Stephens | Overweight |
| 2018-12-24 | 開始されました | Edward Jones | Buy |
| 2018-03-13 | 開始されました | Bernstein | Mkt Perform |
| 2018-03-08 | 開始されました | Barclays | Overweight |
| 2018-01-03 | 開始されました | Goldman | Neutral |
| 2017-11-03 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-06-22 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-06-12 | 開始されました | Credit Suisse | Outperform |
| 2017-06-07 | 開始されました | Morgan Stanley | Overweight |
| 2017-05-08 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-04-05 | 開始されました | Deutsche Bank | Buy |
すべてを表示
Cigna Group (CI) 最新ニュース
Cigna FTC Settlement Reshapes Express Scripts Model And Investor Outlook - simplywall.st
Bloomfield-based health-care giant Cigna Group and FTC settle insulin-price lawsuit - CT Insider
Cigna Executives See Little ’26 Movement in Enrollment, Cost Ratio - HCI Innovation Group
Cigna Group (CI) Analyst Rating Update: RBC Capital Maintains wi - GuruFocus
FTC Deal Reshapes Cigna’s Express Scripts Margins And PBM Positioning - simplywall.st
News | Insurance giant Cigna sheds half of its downtown Philadelphia hub - CoStar
Is The Cigna Group Gaining or Losing Market Support? - Benzinga
Cigna Shows Greater Stability Amid Policy Uncertainty, RBC Says - marketscreener.com
Cigna Group (CI) Buy Rating Maintained by Guggenheim with Increa - GuruFocus
Cigna Group (CI) Analyst Rating: Barclays Lowers Price Target | - GuruFocus
RBC Trims Price Target on Cigna Group to $333 From $344, Keeps Outperform Rating - marketscreener.com
Cigna Corporation (NYSE:CI) Q4 2025 Earnings Call Transcript - Insider Monkey
CI Q4 Deep Dive: PBM Model Transition and Specialty Growth Drive Positive Results - Finviz
Cigna Group Q4 Earnings Call Highlights - Yahoo Finance
Cigna posts US$6 billion profit on double‑digit 2025 revenue growth - Insurance Business
Cigna posts $6 billion profit on double‑digit 2025 revenue growth - Insurance Business
FTC, Cigna settle PBM insulin lawsuit - Modern Healthcare News
Cigna’s Reassurances About PBM Business Lift Stock - The Wall Street Journal
Cigna beats quarterly estimates, provides muted outlook | Business Information & News | FE - Westlaw Today
Cigna Earnings Call: Growth Holds Amid PBM Overhaul - TipRanks
The Cigna Group (CI) Q4 2025 Earnings Call Highlights: Strong Re - GuruFocus
Website Wiretapping Claims Trimmed From Cigna Suit - Law360
CignaContinued Downside In 2026E (NYSE:CI) - Seeking Alpha
The Cigna Group (CI) Stock Price Up 2.81% on Feb 5 - GuruFocus
Cigna hails pharmacy deal with the FTC, battles elevated cost trends - InsuranceNewsNet
Cummins Revenue Holds Up as Charges Weigh on Near-Term Earnings Clarity - Investing.com
3 takeaways from Cigna’s 2025 earnings call - Managed Healthcare Executive
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes - Yahoo Finance
Is Cigna Group (CI) Pricing Look Attractive After Recent Share Price Weakness - simplywall.st
Cigna Group Online Tracking Suit Shrinks to Fiduciary Duty Claim - Bloomberg Law News
FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings - Benzinga
Cigna CEO predicts steady PBM margins amid settlement, health law - Modern Healthcare News
Cigna CEO Cordani says Express Scripts' new PBM model aligns with reforms, FTC settlement - Fierce Healthcare
Cigna (CI) Q4 2025 Earnings Call Transcript - The Globe and Mail
Cigna posts ‘low-drama’ fourth quarter following major FTC settlement - Healthcare Dive
Cigna reports better-than-expected Q4 financial results - Healthcare Finance News
Make Your Portfolio Healthy Again: The Cigna Group (NYSE:CI) - Seeking Alpha
Cigna earnings: COO talks results, making healthcare more affordable - Yahoo Finance
Cigna posts strong earnings as FTC lawsuit settlement announced - Hartford Business Journal
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement - TechStock²
The Cigna Group Declares Quarterly Dividend, Payable on March 19, 2026 - marketscreener.com
Earnings call transcript: Cigna beats Q4 2025 earnings expectations, stock rises - Investing.com
FTC reaches 'landmark settlement' with Cigna's Express Scripts - Healthcare Finance News
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Cigna’s 2026 earnings floor falls short of Wall Street estimates - Modern Healthcare News
Cigna beats quarterly estimates, provides muted outlook - marketscreener.com
Cigna (CI) Surpasses Q4 Expectations with Strong Revenue Growth - GuruFocus
Cigna reports Q4 adjusted EPS $8.08 - marketscreener.com
Cigna (CI) Increases Quarterly Dividend to $1.56 Per Share - GuruFocus
Cigna’s (NYSE:CI) Q4 CY2025 Sales Beat Estimates - The Globe and Mail
Q4 Earnings: KKR and Cummins Miss EPS, Cigna Beats - Tokenist
Cigna Group (CI) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):